Press Room

There are 3 item(s) tagged with the keyword "diabetic macular edema (DME)".

1. iCo Therapeutics and JDRF Partnership Goes Beyond Clinical Advancement

VANCOUVER (June 5, 2013) - iCo and JDRF established a partnership in September 2011 when they joined forces on the iDEAL Study to improve outcomes for people affected by diabetic macular edema (DME).

2. iCo Therapeutics and JDRF Team Up

March 28, 2012, Vancouver, Canada—iCo Therapeutics (TSX-V: ICO), a Vancouver-based drug reprofiling company and JDRF, the largest charitable funder of type 1 diabetes (T1D) research have joined forces to investigate a potential new treatment for one of the most common ...

3. KalVista Pharmaceuticals and JDRF form research partnership

Southampton, UK and New York, USA 09 January 2012 - KalVista Pharmaceuticals ("KalVista") and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease. D...

Lets turn type one into type none